全文获取类型
收费全文 | 58273篇 |
免费 | 3927篇 |
国内免费 | 869篇 |
专业分类
耳鼻咽喉 | 1355篇 |
儿科学 | 2259篇 |
妇产科学 | 1495篇 |
基础医学 | 6471篇 |
口腔科学 | 1925篇 |
临床医学 | 4902篇 |
内科学 | 11449篇 |
皮肤病学 | 1767篇 |
神经病学 | 3956篇 |
特种医学 | 2645篇 |
外国民族医学 | 3篇 |
外科学 | 9936篇 |
综合类 | 1638篇 |
现状与发展 | 1篇 |
一般理论 | 25篇 |
预防医学 | 2273篇 |
眼科学 | 1733篇 |
药学 | 4594篇 |
4篇 | |
中国医学 | 773篇 |
肿瘤学 | 3865篇 |
出版年
2023年 | 494篇 |
2022年 | 365篇 |
2021年 | 1442篇 |
2020年 | 977篇 |
2019年 | 1385篇 |
2018年 | 1836篇 |
2017年 | 1433篇 |
2016年 | 1759篇 |
2015年 | 2013篇 |
2014年 | 2536篇 |
2013年 | 3109篇 |
2012年 | 4173篇 |
2011年 | 4549篇 |
2010年 | 2638篇 |
2009年 | 2014篇 |
2008年 | 3428篇 |
2007年 | 3530篇 |
2006年 | 3376篇 |
2005年 | 3331篇 |
2004年 | 2895篇 |
2003年 | 2766篇 |
2002年 | 2558篇 |
2001年 | 1608篇 |
2000年 | 1670篇 |
1999年 | 1277篇 |
1998年 | 515篇 |
1997年 | 442篇 |
1996年 | 378篇 |
1995年 | 304篇 |
1994年 | 265篇 |
1993年 | 162篇 |
1992年 | 428篇 |
1991年 | 307篇 |
1990年 | 347篇 |
1989年 | 302篇 |
1988年 | 298篇 |
1987年 | 250篇 |
1986年 | 222篇 |
1985年 | 203篇 |
1984年 | 162篇 |
1983年 | 135篇 |
1982年 | 95篇 |
1981年 | 95篇 |
1980年 | 84篇 |
1979年 | 154篇 |
1978年 | 94篇 |
1977年 | 78篇 |
1976年 | 64篇 |
1975年 | 64篇 |
1974年 | 68篇 |
排序方式: 共有10000条查询结果,搜索用时 55 毫秒
1.
Kevin Kyung Ho Choi Santosh Sanagapalli 《World journal of gastrointestinal oncology》2022,14(3):568-586
Barrett's esophagus (BE) is the precursor to esophageal adenocarcinoma (EAC). Progression to cancer typically occurs in a stepwise fashion through worsening dysplasia and ultimately, invasive neoplasia. Established EAC with deep involvement of the esophageal wall and/or metastatic disease is invariably associated with poor long-term survival rates. This guides the rationale of surveillance of Barrett’s in an attempt to treat lesions at an earlier, and potentially curative stage. The last two decades have seen a paradigm shift in management of Barrett’s with rapid expansion in the role of endoscopic eradication therapy (EET) for management of dysplastic and early neoplastic BE, and there have been substantial changes to international consensus guidelines for management of early BE based on evolving evidence. This review aims to assist the physician in the therapeutic decision-making process with patients by comprehensive review and summary of literature surrounding natural history of Barrett’s by histological stage, and the effectiveness of interventions in attenuating the risk posed by its natural history. Key findings were as follows. Non-dysplastic Barrett’s is associated with extremely low risk of progression, and interventions cannot be justified. The annual risk of cancer progression in low grade dysplasia is between 1%-3%; EET can be offered though evidence for its benefit remains confined to highly select settings. High-grade dysplasia progresses to cancer in 5%-10% per year; EET is similarly effective to and less morbid than surgery and should be routinely performed for this indication. Risk of nodal metastases in intramucosal cancer is 2%-4%, which is comparable to operative mortality rate, so EET is usually preferred. Submucosal cancer is associated with nodal metastases in 14%-41% hence surgery remains standard of care, except for select situations. 相似文献
2.
Mahmut Gümüş MD Chieh-I Chen MPH Cristina Ivanescu PhD Saadettin Kilickap MD Igor Bondarenko MD Mustafa Özgüroğlu MD Miranda Gogishvili MD Haci M. Turk MD Irfan Cicin MD James Harnett PharmD Vera Mastey MS Ulrike Naumann MS Matthew Reaney MS Gerasimos Konidaris MS Medha Sasane PhD Keri J. S. Brady PhD Siyu Li PhD Giuseppe Gullo MD Petra Rietschel MD Ahmet Sezer MD 《Cancer》2023,129(1):118-129
3.
Journal of Public Health - The first Covid-19 cases were reported in Malaysia on 25 January 2019 followed by a quiescent period before an upward swing of the cases at the end of February 2020,... 相似文献
4.
5.
6.
7.
目的 通过网络药理学的方法进行预测,再深一步进行动物实验验证来研究柴胡疏肝散治疗CAG的作用机制。方法 首先在TCMSP数据库中检索柴胡疏肝散的所有活性成分与药物靶点;通过收集PharmGkb、OMIM、GeneCards和DrugBank数据库中收录的慢性萎缩性胃炎的相关靶点。将药物靶点与疾病靶点进行映射筛选出交集靶点,将得到的交集靶点构建PPI网络与活性成分-共同靶点网络,并对其进行GO和KEGG富集分析。最后利用Vina软件进行分子对接实验验证,并通过免疫印迹法验证柴胡疏肝散对两种受体蛋白EGFR和STAT1的影响。结果 最终筛选得到柴胡疏肝散活性成分104个,潜在靶点238个,与慢性萎缩性胃炎的交集靶点52个;GO与KEGG富集分析分别得到2166条目和148条目,主要涉及到JAK-STAT信号通路、TNF信号通路、HIF-1信号通路等;分子对接结果显示EGFR、STAT1两个靶点能够与核心活性成分能够自发结合成较为稳定的构像;免疫印迹法实验证明柴胡疏肝散能够降低大鼠胃黏膜组织EGFR和STAT1蛋白表达。结论 通过网络药理学和实验验证,发现柴胡疏肝散可能通过调节EGFR和STAT1蛋白表达来共同调控胃黏膜细胞增殖与凋亡,进而发挥着治疗慢性萎缩性胃炎的效果,为深入进行柴胡疏肝散治疗慢性萎缩性胃炎的作用机制研究提供新思路和新方法。 相似文献
8.
9.
Aydın Fatma Çakar Nilgün Kurt Tuba Çelikel Acar Banu Çelikel Elif Özçakar Zeynep Birsin Yalçınkaya Fatoş 《Clinical rheumatology》2022,41(12):3791-3796
Clinical Rheumatology - Intra-articular corticosteroid injection (IACI) is generally used in the management of juvenile idiopathic arthritis (JIA) to obtain rapid relief of active synovitis and... 相似文献
10.
Proteomic Profiling of Small Extracellular Vesicles Isolated from the Plasma of Vietnamese Patients with Non-Small Cell Lung Cancer Reveals Some Potential Biomarkers 下载免费PDF全文
Thao Phuong Bui Phuong Lan LeLinh Thi Tu Nguyen Le Trung ThoThai Hong Trinh 《Asian Pacific journal of cancer prevention》2022,23(6):1893-1900
Background: Considering the poor prognosis of non-small cell lung cancer (NSCLC), the objective of this study was to examine the potential of plasma-derived vesicles as a source of lung cancer-specific proteins. Extracellular vesicle (EV) cargos are specific to the source cells, hence they have the potential of being a source of cancer-specific proteins. Methods: The proteins differently expressed in cancer were determined and derived from EVs isolated from the plasma of NSCLC patients at the National Lung Hospital. To this end, purification was done using gel filtration chromatography and ultracentrifugation. In addition, nano liquid chromatography mass spectrometry (LC–MS/MS) was used for analyzing. Results: Fifty-seven EV-derived proteins related to NSCLC were highlighted in this research. Some of them have not been addressed before, such as EEF1A1 (elongation factor 1-α1), KPNB1 (Importin subunit beta 1), SRC (proto-oncogene tyrosine-protein kinase) and ACTC1 (actin, alpha cardiac muscle 1). This list was further confirmed through a comparison with ExoCarta and Vesiclepedia. Conclusion: This study is the first work to show the involvement of several novel proteins of small EV (EEF1A1, KPNB1, SRC, and ACTC1) in the progression of NSCLC. The results suggested that they could serve as novel biomarkers for non-small cell lung cancer in the future. 相似文献